BRPI0716397A2 - mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero. - Google Patents

mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero.

Info

Publication number
BRPI0716397A2
BRPI0716397A2 BRPI0716397-5A2A BRPI0716397A BRPI0716397A2 BR PI0716397 A2 BRPI0716397 A2 BR PI0716397A2 BR PI0716397 A BRPI0716397 A BR PI0716397A BR PI0716397 A2 BRPI0716397 A2 BR PI0716397A2
Authority
BR
Brazil
Prior art keywords
promote osteogenesis
methods
mammalian cell
identify agents
osteogenesis
Prior art date
Application number
BRPI0716397-5A2A
Other languages
English (en)
Inventor
Yuanxiang Zhao
Sheng Ding
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of BRPI0716397A2 publication Critical patent/BRPI0716397A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0716397-5A2A 2006-08-11 2007-08-10 mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero. BRPI0716397A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82218406P 2006-08-11 2006-08-11
US11/836,512 US7601501B2 (en) 2006-08-11 2007-08-09 Controlling osteogenesis by inhibition of osteogenic suppressors
PCT/US2007/017797 WO2008019159A2 (en) 2006-08-11 2007-08-10 Controlling osteogenesis by inhibition of osteogenic suppressors

Publications (1)

Publication Number Publication Date
BRPI0716397A2 true BRPI0716397A2 (pt) 2013-09-17

Family

ID=39033527

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716397-5A2A BRPI0716397A2 (pt) 2006-08-11 2007-08-10 mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero.

Country Status (11)

Country Link
US (2) US7601501B2 (pt)
EP (1) EP2049158A4 (pt)
JP (1) JP2010500567A (pt)
KR (1) KR20090047508A (pt)
AU (1) AU2007281931A1 (pt)
BR (1) BRPI0716397A2 (pt)
CA (1) CA2659437A1 (pt)
IL (1) IL196760A0 (pt)
MX (1) MX2009001372A (pt)
RU (1) RU2009108662A (pt)
WO (1) WO2008019159A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009020601A2 (en) 2007-08-03 2009-02-12 Cornell University Atf4 inhibitors and their use for neural protection, repair, regeneration, and plasticity
JP5602850B2 (ja) * 2009-07-14 2014-10-08 ザ スクリプス リサーチ インスティテュート 間葉幹細胞分化
EP2380595A1 (en) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
AU2012308302A1 (en) * 2011-09-14 2014-03-20 Northwestern University Nanoconjugates able to cross the blood-brain barrier
WO2017053963A1 (en) 2015-09-25 2017-03-30 Cedars-Sinal Medical Center A method effective to modulate expression of t-box protein 4 (tbx4) for reducing progression of lung fibrosis after a lung injury
US11725056B2 (en) 2017-10-03 2023-08-15 Cedars-Sinai Medical Center Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis
AU2019406186A1 (en) * 2018-12-20 2021-07-15 Praxis Precision Medicines, Inc. Compositions and methods for the treatment of KCNT1 related disorders
CR20210519A (es) * 2019-03-15 2021-11-24 Ionis Pharmaceuticals Inc Compuestos y métodos para reducir la expresión de kcnt1
JP2022535717A (ja) 2019-05-24 2022-08-10 エンピリコ インク． アンジオポエチン様７（ａｎｇｐｔｌ７）関連疾患の処置
US12565653B2 (en) 2019-11-22 2026-03-03 Alnylam Pharmaceuticals, Inc. ATAXIN3 (ATXN3) RNAi agent compositions and methods of use thereof
EP4247952A2 (en) * 2020-11-23 2023-09-27 Phyzat Biopharmaceuticals, Lda. Sina molecules, methods of production and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006438A1 (en) 1992-09-11 1994-03-31 The Regents Of The University Of California Adenosine analogues and method of increasing adenosine release
WO2002074961A1 (en) * 2001-03-15 2002-09-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2003064470A2 (en) * 2002-02-01 2003-08-07 Bayer Healthcare Ag Regulation of human calcium-activated potassium channel protein
EP1556129A4 (en) 2002-10-15 2011-02-09 Irm Llc COMPOSITIONS AND METHODS OF INDUCING OSTEOGENESIS
US20040241720A1 (en) * 2003-02-26 2004-12-02 Salkoff Lawrence B. Sodium activated potassium ion channel for therapeutic drug screening
WO2005047524A2 (en) 2003-11-10 2005-05-26 The Scripps Research Institute Compositions and methods for inducing cell dedifferentiation
US20060020036A1 (en) * 2004-06-24 2006-01-26 Luc Van Rompaey Methods and compositions to promote bone homestasis
WO2006017211A1 (en) 2004-07-12 2006-02-16 Research Development Foundation Guggulsterone as an inhibitor of nuclear factor-kb and ikbalpha kinase activation

Also Published As

Publication number Publication date
AU2007281931A1 (en) 2008-02-14
RU2009108662A (ru) 2010-09-20
MX2009001372A (es) 2009-02-13
IL196760A0 (en) 2011-08-01
US7601501B2 (en) 2009-10-13
EP2049158A4 (en) 2010-04-07
WO2008019159A2 (en) 2008-02-14
WO2008019159A3 (en) 2009-04-16
CA2659437A1 (en) 2008-02-14
US20080038202A1 (en) 2008-02-14
JP2010500567A (ja) 2010-01-07
EP2049158A2 (en) 2009-04-22
US20100184113A1 (en) 2010-07-22
KR20090047508A (ko) 2009-05-12

Similar Documents

Publication Publication Date Title
BRPI0716397A2 (pt) mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero.
BRPI0813710A2 (pt) Enzimas que produzem acetil-coa em levedura
BRPI0809655A2 (pt) Método para tratar uma condição em um mamífero, composição farmacêutica, e, kit
BRPI0917475A2 (pt) caralisador que compreende uma zeólita izm-2 e pelo menos um metal e sua utilização em tranformação de hidrocarbonetos
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0717068A2 (pt) instruÇço e làgica para processar cadeias de texto.
DK2064333T3 (da) Suppressor-trna-transkription i hvirveldyrceller
BRPI0908177A2 (pt) compósito elástico e método para produzir o mesmo
BRPI0813463A2 (pt) Aperfeiçoamento em membros estruturais compósitos alongados
PL1989400T5 (pl) Sposób magazynowania energii i układ magazynowania energii kriogenicznej
FI20075613L (fi) Sovitelma ja menetelmä kuormitusvasteen parantamiseksi aluksessa
BRPI0918632A2 (pt) dispositivo de separação com dupla transmissão e método de reduzir a formação de roscas em um dispositivo de separação.
DK2125069T3 (da) Indretning til stof- og eller energiudveksling
PT2119778E (pt) Método para ativação de célula t auxiliar e composição para utilização no método
BR112012005778A2 (pt) método e sistema para simulação em uma subestação
EP2165609A4 (en) MEANS FOR IMPROVED PANSEN FERMENTATION
BR112013014857A2 (pt) processo para a frezagem de uma reentrância em uma peça de trabalho e peça de trabalho com uma reentrância.
DK2274430T3 (da) Nerveregenererende celler med ændringer i dna-methylering
FI20095897A0 (fi) Menetelmä ja laitteisto jätekuilussa
BRPI0906438A2 (pt) Isolamento de conteúdo por meio de processos em uma aplicação
BRPI0722063A2 (pt) Processo e dispositivo para determinação de populações menores de célula em populações de células heterogêneas
BRPI0814837A2 (pt) parafuso, método de substituição de um parafuso em uma dobradiça, kit, sistema para orientar um parafuso em uma dobradiça
BRPI0909689A2 (pt) dispositivo de autoendereçamento em uma fonte comum e estrutura de comunicação de barramento e método para sua realização
BRPI0816722A2 (pt) Conexão para o uso com tubulações de metal em uma jaqueta e conexão acoplada a tubulações de metal em uma jaqueta
FI20085639L (fi) Paristotarra ja paristo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]